May 29, 2020
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.99 to $11.88.
The split itself did not change the total investment value.
Larimar Therapeutics, Inc. (NASDAQ:LRMR) operates in the Biotechnology industry.
Larimar Therapeutics, Inc. company overviewLarimar Therapeutics, Inc.'s most recent stock split was on May 29, 2020. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Larimar Therapeutics, Inc. has split its stock once. This history records one reverse split, on May 29, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Larimar Therapeutics, Inc.'s 1-for-12 reverse split on May 29, 2020, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Larimar Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on May 29, 2020, 6 years ago. Companies announce splits in advance, and any new NASDAQ:LRMR split will appear on this page.